NIH Office for Research on Women's Health - Office of Autoimmune Research
Active
- Assistance listing
- 93.ADR
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Also known as
- ORWH-OADR
- Treasury account
-
- 75-1208-4-6-000
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institutes of Health Office for Research on Women's Health, through its Office of Autoimmune Research (CFDA 93.ADR), funds identification, coordination, and support of autoimmune disease research projects across NIH institutes and multidisciplinary research entities, with no recent grant awards or open opportunities reported in the current portfolio snapshot.
The program's core mission centers on identifying autoimmune disease and autoimmune disorder research that should be conducted or supported by national research institutes, identifying multidisciplinary research related to autoimmunity for potential NIH support, and promoting coordination and collaboration among research-performing entities. The program description does not surface recent grant awards or award volumes, preventing assessment of typical award magnitudes, recent award cadence, or recent recipient activity. No funding opportunity announcements are currently open or recently posted.
Eligible applicants include domestic public or private nonprofit organizations, universities, hospitals, laboratories, state and local government units, and individuals; small businesses (under 500 employees) are eligible, and some initiatives accept applications from foreign organizations. Specific eligibility constraints appear in individual funding opportunity announcements.
Applications undergo competitive peer review for scientific and technical merit by scientific review groups and for program relevance by a national advisory council or board. Administrative supplements are reviewed for merit and relevance by NIH scientific staff and are not renewable. Applicants may question substantive or procedural aspects of applications through communication with NIH scientific and research contacts.
Grant recipients must retain financial, programmatic, and statistical records for three years from the date of annual Federal Funding Status Reports submission, with extensions required if litigation, claims, audits, or financial management reviews are initiated before the retention period expires. The program is excluded from Executive Order 12372 coverage, and preapplication coordination and environmental impact assessment are not required.
Because the source provides no recent awards, award dollars, or posted opportunities, pursue-worthiness cannot be assessed from activity signals. Prospective applicants should monitor NIH's funding opportunity portal for CFDA 93.ADR solicitations and contact the Office for Research on Women's Health directly to determine current solicitation status and research priorities.
Objective and description
- Objective
ORWH-OADR will identify projects on autoimmune diseases that should be conducted or supported by national research institutes; identify multi-disciplinary research related to autoimmunity that should be conducted or supported; and promote coordinati
- Description
ORWH-OADR will identify projects on autoimmune diseases that should be conducted or supported by national research institutes; identify multi-disciplinary research related to autoimmunity that should be conducted or supported; and promote coordination and collaboration among entities conducting research.
Eligibility
- Applicant eligibility
State (includes District of Columbia, public institutions of higher education and hospitals), Public nonprofit institution/organization (includes institutions of higher education and hospitals), U.S. Territories and possessions (includes institutions of higher education and hospitals), Small business (less than 500 employees), Private nonprofit institution/organization (includes institutions of higher education and hospitals) Awards can be made to domestic, public or private, non-profit or profit organization, university, hospital, laboratory, or other institution including state and local units of government and individuals. Some initiatives will accept applications from foreign organizations. Additional details on eligibility will be specified in the funding opportunity announcement
- Uses of assistance
Specific Restrictions Determined at NOFO Level Higher Education (includes Research), Training To support research and other projects that will accelerate biomedical and behavioral discovery and translation of that knowledge into effective prevention strategies and new treatments. Use Restrictions Awards are limited by availability of funds. Specific restrictions are outlined in each funding opportunity announcement. Higher Education (includes Research), Training To support research and other projects that will accelerate biomedical and behavioral discovery and translation of that knowledge into effective prevention strategies and new treatments. Use Restrictions Awards are limited by availability of funds. Specific restrictions are outlined in each funding opportunity announcement.
- Use restrictions
Specific Restrictions Determined at NOFO Level Use Restrictions Awards are limited by availability of funds. Specific restrictions are outlined in each funding opportunity announcement.
How to apply
- Preapplication coordination
Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
- Criteria for selecting proposals
ORWH-OADR will identify projects on autoimmune disorders that should be conducted or supported by national research institutes; identify multi-disciplinary research related to autoimmune disorders research on that should be conducted or supported.
- Award procedure
Competitive peer reviewed applications are reviewed for scientific and technical merit by a scientific review group; and for program relevance by a national advisory council/board. Administrative supplements are reviewed for merit and relevance by NIH scientific staff.
- Renewals
Renewals Not Applicable. Administrative supplements are not renewable. Other programs may be renewable and applicants must review the funding opportunity announcement for further guidance.
- Appeals
Not Applicable. A principal investigator may question the substantive or procedural aspects of his/her application by communication with the NIH scientific/research contact as provided in the initiative.
Quick answers
What is Assistance Listing 93.ADR?
Assistance Listing 93.ADR is NIH Office for Research on Women's Health - Office of Autoimmune Research, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for NIH Office for Research on Women's Health - Office of Autoimmune Research?
Its CFDA number is 93.ADR: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program